Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
260 employees
AtriCure, Inc. develops and sells surgical devices for precise lesion creation in soft tissues, serving customers globally.
HQ
Founded
2000
AtriCure, Inc. develops and manufactures surgical devices for creating precise lesions in soft tissues, focusing on treatments for atrial fibrillation. The company's product line includes bipolar ablation systems and the cryoSPHERE+ probe for post-operative pain management. AtriCure serves cardiothoracic surgeons worldwide, offering innovative solutions for heart rhythm disorders and related conditions.
AtriCure is committed to reducing the global atrial fibrillation epidemic through its advanced medical technologies. The company's AtriClip device for Left Atrial Appendage Management has become widely adopted worldwide. AtriCure continues to innovate in the field of cardiac surgery, participating in healthcare conferences and focusing on non-opioid solutions for post-operative pain management.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pain Management, Surgical Devices
Technology
Robotics
Tags
Healthtech
Model Types
Hardware, Medical Devices
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Global
When was AtriCure founded?
AtriCure was founded in 2000.
Where is AtriCure's headquarters located?
AtriCure's headquarters is located in DE, US.
How many employees does AtriCure have?
AtriCure has 260 employees as of Feb 6, 2024.
How much has AtriCure raised to-date?
As of July 05, 2023, AtriCure has raised a total of $26M (USD) since Jan 1, 2005.
Add Comparison
Total Raised to Date
$26M
USD
Last Update Jan 1, 2005
Current Employees
260
Last updated: Feb 6, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts